(1-(5-Hydroxypentyl)-1H-indol-3-yl)(naphthalen-1-yl)methanone
CAS: 335161-21-2
Ref. 3D-KNA16121
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar |
Información del producto
AB-FUBINACA is a synthetic cannabinoid that is an agonist of the cannabinoid receptors. It is used in scientific research to study the endocannabinoid system, as well as for its potential application in treating neurological disorders such as epilepsy and multiple sclerosis. AB-FUBINACA binds to the CB1 receptor, which inhibits adenylate cyclase and lowers cAMP levels. This results in reduced activity of protein kinase A (PKA), which may play a role in seizure generation or epileptogenesis. The compound has been shown to be effective against the symptoms of Parkinson's disease, including tremors and postural instability. AB-FUBINACA also has analgesic properties and can be used to treat chronic pain syndromes such as fibromyalgia, rheumatoid arthritis, and neuropathic pain.
AB-FUBINACA has been detected in urine samples using GC/MS following chromatographic separation with acetonitrile as the mobile
Propiedades químicas
Consulta técnica sobre: 3D-KNA16121 (1-(5-Hydroxypentyl)-1H-indol-3-yl)(naphthalen-1-yl)methanone
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
